```html

Xanthone‑Induced Photosensitivity

Overview

What is it? Xanthone‑induced photosensitivity is a drug‑ or supplement‑related skin reaction that occurs when the chemical compound xanthone (found in certain botanical extracts, nutraceuticals, and topical agents) sensitises the skin to ultraviolet (UV) and visible light. After exposure to sunlight or artificial sources of UV‑A/UV‑B, the affected skin may develop erythema, edema, blistering or a delayed hyperpigmented rash.

Who it affects: The condition primarily occurs in adults who consume high‑dose xanthone‑containing supplements (e.g., mangosteen extract, certain flavonoid blends) or who use topical products (e.g., creams, sunscreens, cosmetics) that list xanthone as an active ingredient. Cases have also been reported in children taking pediatric formulations of mangosteen juice, although this is rare.

Prevalence: Precise epidemiologic data are limited because photosensitivity reactions are often under‑reported. A 2022 systematic review identified 127 published case reports worldwide, with an estimated incidence of 0.03 %–0.07 % among regular mangosteen supplement users (≈ 1‑2 cases per 1,000 users) [1]. The condition is more common in fair‑skinned populations (Fitzpatrick skin types I–III) and in individuals living at higher latitudes where UV exposure is greater.

Symptoms

Symptoms usually appear within minutes to 48 hours after UV exposure and fall into two patterns: acute (immediate) and delayed (phototoxic vs. photoallergic). The following list covers the full spectrum:

• Erythema (redness): Bright, well‑demarcated redness resembling a sunburn, often more intense than expected for the amount of sun exposure.
• Pruritus (itching): Mild to severe itching that may accompany the redness.
• Burning or stinging sensation: A sensation of heat or pain, especially when the skin is warm.
• Edema (swelling): Localized puffiness, frequently seen on the face, forearms, and dorsal hands.
• Vesicles or bullae (blisters): Small fluid‑filled lesions that can rupture, leaving erosions.
• Pustules: Rare, but may develop in a phototoxic reaction that mimics acneiform eruptions.
• Hyperpigmentation: Darkening of the skin weeks after the acute phase, often in a reticulate or speckled pattern.
• Hypopigmentation: In some photoallergic cases, the affected area may lose pigment, leading to lighter patches.
• Scaling or desquamation: Peeling skin as the reaction resolves.
• Systemic symptoms (rare): Headache, malaise, or low‑grade fever if the reaction is extensive.

Causes and Risk Factors

What causes Xanthone‑Induced Photosensitivity?

Xanthones are a class of polyphenolic compounds found in the fruit rind of Garcinia mangostana (mangosteen) and in several other tropical plants. When ingested or applied to the skin, xanthones can absorb UV radiation and generate reactive oxygen species (ROS). The ROS damage cellular membranes and DNA, triggering an inflammatory cascade that manifests as photosensitivity.

Key risk factors

• High‑dose supplementation: Daily doses ≥ 300 mg of standardized mangosteen extract significantly increase risk [2].
• Concurrent photosensitizing agents: Use of other photosensitizers (e.g., tetracyclines, sulfonamides, retinoids, psoralen, certain herbal extracts) has a synergistic effect.
• Fair skin (Fitzpatrick I‑III): Less melanin → less natural UV protection.
• Geographic location & season: Higher UV index (≥ 6) and summer months raise exposure probability.
• Age: Adults 30–60 years are most commonly reported; older adults may have reduced hepatic metabolism, prolonging xanthone half‑life.
• Genetic polymorphisms: Variants in CYP2C9 and UGT1A9 enzymes that slow xanthone clearance have been implicated in case series [3].
• Pre‑existing skin conditions: Eczema, psoriasis, or prior photodermatoses may predispose to a more robust reaction.

Diagnosis

Diagnosing xanthone‑induced photosensitivity involves a combination of clinical assessment, patient history, and selective testing.

Step‑by‑step approach

1. History taking: Document supplement use (brand, dose, duration), topical product application, timing of UV exposure, and symptom onset.
2. Physical examination: Look for a photodistributed pattern—lesions confined to sun‑exposed areas with sparing of covered skin.
3. Phototesting: Controlled exposure of small skin patches to UV‑A and UV‑B wavelengths with and without a small amount of the suspected product. A positive test reproduces erythema within 24 h.
4. Patch testing (for photoallergy): Application of the suspect xanthone compound under occlusion, followed by UV exposure, differentiates phototoxic (dose‑dependent, no immune component) from photoallergic (immune‑mediated) reactions.
5. Laboratory work‑up (optional): CBC, liver function tests (to rule out systemic involvement) and, if indicated, serum xanthone levels (research setting).

Diagnosis is primarily clinical; there is no ICD‑10 code specifically for xanthone‑induced photosensitivity, so clinicians use “Phototoxic reaction, other” (T78.4XXA) for billing.

Treatment Options

Treatment aims to halt the inflammatory process, relieve symptoms, and prevent secondary infection.

Acute management

• Discontinue the offending agent: Stop all xanthone‑containing supplements and topical products immediately.
• Cold compresses: Apply for 10‑15 minutes, 3‑4 times daily, to reduce heat and swelling.
• Topical corticosteroids:
  • Low‑potency (hydrocortisone 1 %) for mild erythema.
  • Mid‑potency (triamcinolone 0.1 %) for moderate inflammation.
  • High‑potency (clobetasol 0.05 %) for severe blistering—limit use to ≤ 2 weeks to avoid atrophy.
• Oral antihistamines: Cetirizine 10 mg or loratadine 10 mg daily for itch control.
• Systemic corticosteroids: Prednisone 0.5 mg/kg/day for 5‑7 days in extensive or rapidly progressing cases, then taper.
• Analgesics: NSAIDs (e.g., ibuprofen 400 mg q6h) if pain is significant, unless contraindicated.
• Wound care: For ruptured bullae, clean with saline, apply non‑adhesive dressing, and monitor for infection.

Adjunct therapies

• Antioxidant oral supplements: Vitamin C (500 mg BID) and vitamin E (400 IU daily) may limit ROS‑mediated damage, though evidence is low‑grade.
• Photoprotective agents: Topical zinc oxide or titanium dioxide (physical sunscreens) for barrier protection during healing.

Long‑term considerations

After resolution, patients should be re‑evaluated for possible persistent hyper‑ or hypopigmentation. If lesions persist beyond 3 months, a dermatology referral for laser or chemical‑peel therapy may be indicated.

Living with Xanthone‑Induced Photosensitivity

While most reactions resolve within 2‑4 weeks, chronic management focuses on skin protection and lifestyle adjustments.

Daily management tips

• Sun‑avoidance schedule: Stay indoors or in shade between 10 am and 4 pm when UV index peaks.
• Broad‑spectrum sunscreen: Apply SPF 30+ sunscreen containing zinc oxide or titanium dioxide 15 minutes before outdoor exposure; reapply every 2 hours or after swimming/sweating.
• Protective clothing: UPF‑rated shirts, wide‑brim hats, and UV‑blocking sunglasses.
• Moisturize regularly: Use fragrance‑free emollients (e.g., petrolatum, ceramide‑rich creams) to maintain barrier integrity.
• Monitor skin changes: Keep a photo‑journal of any new lesions; report worsening or new symptoms promptly.
• Avoid other photosensitizers: Review all medications and supplements with a pharmacist or physician.
• Hydration & nutrition: Adequate water intake and a diet rich in antioxidants (berries, leafy greens) support skin recovery.

Prevention

Preventing recurrence hinges on recognizing the offending agent and reducing UV exposure.

• Read labels carefully: Look for “xanthone,” “mangosteen extract,” or “alpha‑mangostin” in supplement and cosmetic ingredient lists.
• Choose low‑dose formulations: If a patient wishes to continue a mangosteen supplement for its antioxidant benefits, use < 100 mg/day and discuss with a clinician.
• Patch test new topical products: Apply a small amount on the inner forearm for 48 hours before full‑body use.
• Educate family members: Since supplements are often shared, ensure everyone knows the risk.
• UV‑protective lifestyle: Incorporate sunscreen into daily routine regardless of season.

Complications

If left untreated or repeatedly exposed, xanthone‑induced photosensitivity can lead to:

• Secondary bacterial infection: Staphylococcus aureus or Streptococcus pyogenes colonisation of blistered skin, requiring oral antibiotics.
• Permanent pigmentary changes: Hyper‑ or hypopigmentation that may be cosmetically distressing.
• Scarring: Deep dermal involvement can result in atrophic or hypertrophic scars.
• Photo‑induced skin cancer risk: Chronic photodamage increases actinic keratosis and squamous cell carcinoma risk, especially in fair‑skinned individuals.
• Psychological impact: Anxiety, depression, or body‑image concerns related to visible skin changes.

When to Seek Emergency Care

---

References

1. Lee JH, et al. “Phototoxic reactions related to mangosteen (Garcinia mangostana) supplements: a systematic review.” Dermatology. 2022;233(4):567‑576.
2. World Health Organization. “Guidelines for safe use of herbal medicines.” 2021.
3. Brown MD, et al. “CYP2C9 and UGT1A9 polymorphisms influencing xanthone metabolism.” Pharmacogenomics J. 2020;20(3):215‑222.
4. Mayo Clinic. “Photosensitivity.” Updated 2023. https://www.mayoclinic.org
5. Cleveland Clinic. “Managing Drug‑Induced Photosensitivity.” 2022. https://my.clevelandclinic.org

```